Predictors and Prognostic Significance of Troponin-I Release Following Elective Coronary Angioplasty

Author： Izgi A   Tanalp AC   Kirma C   Dundar C   Oduncu V   Akcakoyun M   Ozveren O   Mutlu B  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.34, Iss.6, 2006-11, pp. : 612-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coronary bypass cost effective, not so angioplasty

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 524, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty

By Hamon M.  

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite

Coumarin + aspirin cost saving for coronary angioplasty in The Netherlands

By  

Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Laser Coronary Angioplasty: History, Present and Future

By Köster R.   Kähler J.   Brockhoff C.   Münzel T.   Meinertz T.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 197-207

Adis International

Access to resources Recommend Favorite

Bivalirudin preferable in coronary angioplasty?

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite